Desktop
BioTechnology
UX Research
UX Design
Talon Biomarkers develops tools that advance immune system research.
Its flagship platform, CytoSoar, helps flow cytometrists efficiently review, organize, and perform quality control on their data.

Timeline
Jan 2025 - May 2025
Role
UI/UX Researcher & Designer
Platform & Tools
Desktop || Figma, Miro, VSCode
Skills
Product Design, Data Analytics
OVERVIEW
Problem Statement
Talon Biomarkers advances immune system research by accelerating the development of targeted therapeutics and diagnostics. The company is developing Cytosoar, a software platform that helps flow cytometrists review and perform quality control on data. However, CytoSoar’s current interface is not intuitive, limiting accessibility for non-technical users and reducing adoption and collaboration.
Main Solutions
Objectives
With CytoSoar still in early development, our team aimed to structure seamless and organized content organization. In addition, we plan to develop UI elements for this new central hub for flow cytometry, and create a standardized flow for Talon Biomarkers employees.
PROCESS
Research
Researched flow cytometry workflows, analysis tools, and user needs, then created a user persona and journey map to identify user pain points.
Needs & Expectations
Information Architecture
Cytosoar had limited prior development, so our team prioritized establishing an organizational structure to define user flow and integrate dashboard tools.
DESIGN SOLUTIONS
FINAL STEPS & TAKEAWAYS
CytoSoar was an early-stage product, which meant the design challenge was more than usability, and focused more on building a foundation that could scale. The work centered on making complex flow cytometry data accessible to both technical and non-technical users without oversimplifying it. The experience sharpened how I think about information architecture and system design in parallel. What we delivered was a clear direction: an scalable component library, workflows, and documented patterns for future teams to build on across Talon Biomarkers.





